Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$102.21 - $122.25 $81,768 - $97,800
-800 Reduced 42.11%
1,100 $128,000
Q1 2024

May 15, 2024

SELL
$105.2 - $126.4 $652,240 - $783,680
-6,200 Reduced 76.54%
1,900 $238,000
Q4 2023

Feb 14, 2024

SELL
$76.46 - $101.74 $168,212 - $223,828
-2,200 Reduced 21.36%
8,100 $824,000
Q3 2023

Nov 14, 2023

BUY
$88.53 - $107.13 $327,561 - $396,381
3,700 Added 56.06%
10,300 $911,000
Q2 2023

Aug 14, 2023

SELL
$87.79 - $109.66 $658,425 - $822,450
-7,500 Reduced 53.19%
6,600 $660,000
Q1 2023

May 15, 2023

BUY
$85.05 - $114.38 $799,470 - $1.08 Million
9,400 Added 200.0%
14,100 $1.35 Million
Q4 2022

Feb 14, 2023

SELL
$85.14 - $125.74 $25,542 - $37,722
-300 Reduced 6.0%
4,700 $539,000
Q3 2022

Nov 14, 2022

SELL
$84.44 - $116.86 $337,760 - $467,440
-4,000 Reduced 44.44%
5,000 $422,000

Others Institutions Holding CURE

About DIREXION DAILY HEALTHCARE BULL


  • Ticker CURE
  • Sector ETFs
  • Industry ETFs
More about CURE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.